Your browser doesn't support javascript.
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
Rama, Tiago Azenha; Moreira, André; Castells, Mariana.
  • Rama TA; Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina, Universidade do Porto, Porto, Portugal. Electronic address: tarama@med.up.pt.
  • Moreira A; Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina, Universidade do Porto, Porto, Portugal; EPIUnit - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Castells M; Brigham and Women's Hospital, Division of Allergy and Clinical Immunology, Harvard Medical School, Boston, Mass.
J Allergy Clin Immunol ; 147(3): 877-878, 2021 03.
Article in English | MEDLINE | ID: covidwho-1036582

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Messenger / Mastocytosis, Systemic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Anaphylaxis / Mast Cells Type of study: Case report Topics: Vaccines Limits: Adult / Female / Humans Language: English Journal: J Allergy Clin Immunol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Messenger / Mastocytosis, Systemic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Anaphylaxis / Mast Cells Type of study: Case report Topics: Vaccines Limits: Adult / Female / Humans Language: English Journal: J Allergy Clin Immunol Year: 2021 Document Type: Article